Balance Sheet Details - Additional Information (Details) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Balance Sheet Related Disclosures [Abstract] | ||||
| Money market funds | $ 19,200 | $ 59,100 | ||
| Restricted cash | 28,600 | 1,000 | ||
| Decrease in inventories | 12,239 | 9,565 | $ 60,636 | |
| Inventory | 78,104 | 90,343 | ||
| Depreciation | 23,200 | 23,000 | 23,800 | |
| Proceeds loaned under notes receivable | $ 10,000 | |||
| Note receivable | 8,800 | |||
| Note receivable, writeoff | 700 | 500 | ||
| First initial repayments of notes receivable due to the company annually | 800 | |||
| Repayments of notes receivable due to the company annually | 2,000 | |||
| Accrued price protection liability | $ 26,493 | $ 43,401 | $ 71,684 | |
| X | ||||||||||
- Definition Accrued price protection liability. No definition available.
|
| X | ||||||||||
- Definition First Initial Repayments Of Notes Receivable Due To The Company No definition available.
|
| X | ||||||||||
- Definition Proceeds Loaned Under Notes Receivable No definition available.
|
| X | ||||||||||
- Definition Repayments of Notes Receivable Due to the Company Annually After Initial Payment No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of writeoff of financing receivable, charged against allowance for credit loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months. No definition available.
|
| X | ||||||||||
- Definition Amortized cost, before allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|